Skip to main content
. 2022 Jan 24;10(2):248. doi: 10.3390/biomedicines10020248

Figure 1.

Figure 1

The complex interaction between cancer and the immune tumor microenvironment (TME) influences the outcome of immunotherapy and of several other anti-cancer therapies. A combined model and algorithm that captures both cancer and TME cells (including the immunosuppressive and immunostimulating cells) features through gene expression profiling may result in better prognosticators for measuring outcome and response to therapies.